EFFICACY STUDIES ON A CANARYPOX-RABIES RECOMBINANT VIRUS

被引：129
|
作者：
TAYLOR, J
TRIMARCHI, C
WEINBERG, R
LANGUET, B
GUILLEMIN, F
DESMETTRE, P
PAOLETTI, E
机构：
[1] VIROGENET CORP,465 JORDAN RD,RENSSELAER TECHNOL PK,TROY,NY 12180
[2] NEW YORK STATE DEPT HLTH,WADSWORTH CTR LABS & RES,ALBANY,NY 12201
[3] RHONE MERIEUX,F-69007 LYONS,FRANCE
来源：
VACCINE | 1991年 / 9卷 / 03期
关键词：
RECOMBINANT; CANARYPOX; RABIES; FOWLPOX; VACCINIA;
D O I：
10.1016/0264-410X(91)90152-V
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Recombinant avipox viruses have been developed expressing the rabies glycoprotein gene. A fowlpox-rabies recombinant has previously been shown to be protective against live rabies virus challenge in a number of non-avian species1. This report describes the development of a canarypox-rabies recombinant. A comparison is made of the protective efficacy of this recombinant with other pox-rabies recombinants.
引用
收藏
页码：190 / 193
页数：4
相关论文
共 50 条
  • [41] CANARYPOX VIRUS AS A VACCINE VECTOR
    不详
    LANCET, 1992, 339 (8807): : 1448 - 1449
  • [42] PROTECTION OF CATS AGAINST FELINE LEUKEMIA-VIRUS BY VACCINATION WITH A CANARYPOX VIRUS RECOMBINANT, ALVAC-FL
    TARTAGLIA, J
    JARRETT, O
    NEIL, JC
    DESMETTRE, P
    PAOLETTI, E
    JOURNAL OF VIROLOGY, 1993, 67 (04) : 2370 - 2375
  • [43] RABIES ERADICATION IN BELGIUM BY FOX VACCINATION USING VACCINIA-RABIES RECOMBINANT VIRUS
    BROCHIER, B
    PASTORET, PP
    ONDERSTEPOORT JOURNAL OF VETERINARY RESEARCH, 1993, 60 (04) : 469 - 475
  • [44] A Novel Rabies Vaccine Based on a Recombinant Bovine Herpes Virus Type 1 Expressing Rabies Virus Glycoprotein
    Zhao, Caiquan
    Gao, Jie
    Wang, Yongzhi
    Ji, Lina
    Qin, Hui
    Hu, Wei
    Yang, Yang
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [45] STUDIES OF RABIES VIRUS IN RELATION TO INSECTS
    SIDOR, C
    ZENTRALBLATT FUR BAKTERIOLOGIE PARASITENKUNDE INFEKTIONSKRANHEITEN UND HYGIENE ABTEILUNG 1-ORIGINALE MEDIZINISCH HYGIENSCHE BAKTERIOLOGIE VIRUSFORSCHUNG UND PARASITOLOGIE, 1966, 201 (04): : 417 - &
  • [46] STUDIES ON RABIES VIRUS SOLUBLE ANTIGEN
    VILLEMOT, JM
    PROVOST, A
    ANNALES DE L INSTITUT PASTEUR, 1959, 96 (06): : 712 - 722
  • [47] Evaluation of concurrent vaccinations with recombinant canarypox equine influenza virus and inactivated equine herpesvirus vaccines
    Lee, Dong-Ha
    Lee, Eun-bee
    Seo, Jong-pil
    Ko, Eun-Ju
    JOURNAL OF ANIMAL SCIENCE AND TECHNOLOGY, 2022, 64 (03) : 588 - 598
  • [48] Safety profile of recombinant canarypox HIV vaccines
    de Bruyn, G
    Rossini, AJ
    Chiu, YL
    Holman, D
    Elizaga, ML
    Frey, SE
    Burke, D
    Evans, TG
    Corey, L
    Keefer, MC
    VACCINE, 2004, 22 (5-6) : 704 - 713
  • [49] A recombinant pseudorabies virus expressing rabies virus glycoprotein: Safety and immunogenicity in dogs
    Yuan, Ziguo
    Zhang, Shoufeng
    Liu, Ye
    Zhang, Fei
    Fooks, Anthony R.
    Li, Qianxue
    Hu, Rongliang
    VACCINE, 2008, 26 (10) : 1314 - 1321
  • [50] Construction and Immunogenicity of a Recombinant Pseudorabies Virus Expressing the Rabies Virus Glycoprotein and EGFP
    Han, Naijun
    Li, Yewei
    Sun, Chenglong
    Meng, Qingguo
    Song, Feifei
    Yang, Yang
    Zhang, Shoufeng
    Hu, Rongliang
    JOURNAL OF ANIMAL AND VETERINARY ADVANCES, 2012, 11 (04): : 567 - 571
12345